- 全部删除
- 您的购物车当前为空
Duligotuzumab 是一种双靶向人IgG1单克隆抗体,可同时结合表皮生长因子受体(EGFR)和人表皮生长因子受体3(HER3)。其通过阻断这两种信号通路并诱导抗体依赖性细胞毒性(ADCC)发挥抗肿瘤作用,靶向治疗由EGFR/HER3过表达相关的肿瘤。
Duligotuzumab 是一种双靶向人IgG1单克隆抗体,可同时结合表皮生长因子受体(EGFR)和人表皮生长因子受体3(HER3)。其通过阻断这两种信号通路并诱导抗体依赖性细胞毒性(ADCC)发挥抗肿瘤作用,靶向治疗由EGFR/HER3过表达相关的肿瘤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 3,980 | In stock | |
5 mg | ¥ 10,370 | In stock | |
10 mg | ¥ 16,600 | In stock |
Duligotuzumab 相关产品
产品描述 | Duligotuzumab is a dual-targeting human IgG1 monoclonal antibody that simultaneously binds to both epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 3 (HER3). Duligotuzumab exerts its antitumor effects by blocking these dual signaling pathways and by inducing antibody-dependent cellular cytotoxicity (ADCC), targeting tumors where EGFR/HER3 overexpression correlates with poor prognosis. |
别名 | 度戈妥珠单抗, RG 7597, MEHD-7945A, Duligotumab |
CAS No. | 1314238-96-4 |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容